ʻO ka PCR Fluorescence
-
ʻO Trichomonas Vaginalis Nucleic Acid
Hoʻohana ʻia kēia kit no ka ʻike qualitative o Trichomonas vaginalis nucleic acid i loko o nā laʻana huna huna urogenital kanaka.
-
Hoʻohui ʻia nā mea maʻi hanu
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o nā pathogens hanu i loko o ka waikawa nucleic i unuhi ʻia mai nā laʻana oropharyngeal swab kanaka.ʻO nā maʻi maʻi i ʻike ʻia: ka maʻi influenza A (H1N1, H3N2, H5N1, H7N9), ka maʻi influenza B (Yamataga, Victoria), ka maʻi parainfluenza (PIV1, PIV2, PIV3), metapneumovirus (A, B), adenovirus (1, 2, 3). , 4, 5, 7, 55), respiratory syncytial (A, B) a me ka maʻi ʻala.
-
14 Nā ʻano o ka HPV Nucleic Acid Type
Hiki i ke kit ke ʻike i nā ʻano papillomavirus he 14 i loko o ka vitro (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) nucleic acid.
-
19 Nā ʻano ʻano o ka ʻakika Nucleic Acid Respiratory Pathogen
Hoʻohana ʻia kēia kime no ka ʻike ʻana i ka qualitative hui ʻia o SARS-CoV-2, ka maʻi influenza A, ka maʻi influenza B, adenovirus, mycoplasma pneumoniae, chlamydia pneumoniae, respiratory syncytial virus a me ka maʻi parainfluenza (Ⅰ, II, III, IV) i loko o ka puʻu ʻāʻī. a me ka sputum samples, metapneumovirus kanaka, haemophilus influenzae, streptococcus pneumoniae, klebsiella pneumoniae, staphylococcus aureus, pseudomonas aeruginosa, legionella pneumophila a me acinetobacter baumannii.
-
Neisseria Gonorrhoeae Nucleic Acid
Hoʻolālā ʻia kēia pahu no ka ʻike in vitro o Neisseria Gonorrhoeae(NG) nucleic acid i loko o ka mimi kāne, ka urethral swab kāne, ka wahine cervical swab samples.
-
ʻEhā ʻano o nā mea hoʻomaʻi hanu nucleic acid
Hoʻohana ʻia kēia kit no ka ʻike qualitative o SARS-CoV-2, influenza A virus, influenza B virus a me respiratory syncytial virus nucleic acids i loko o nā ʻano oropharyngeal swab samples.
-
ʻO ka Mycobacterium Tuberculosis Rifampicin Resistance
He kūpono kēia pahu no ka ʻike qualitative o ka homozygous mutation i loko o ka 507-533 amino acid codon māhele o ka rpoB gene i kumu kū'ē i ka Mycobacterium tuberculosis rifampicin.
-
ʻO ka Cytomegalovirus kanaka (HCMV) Nucleic Acid
Hoʻohana ʻia kēia pahu no ka hoʻoholo ʻana i ka qualitative o nā waikawa nucleic i nā laʻana me ka serum a i ʻole ka plasma mai nā mea maʻi i manaʻo ʻia he maʻi HCMV, i mea e kōkua ai i ka hōʻoia ʻana o ka maʻi HCMV.
-
Mycobacterium Tuberculosis Nucleic Acid a me Rifampicin Resistance
He kūpono kēia kit no ka ʻike qualitative o Mycobacterium tuberculosis DNA i loko o nā laʻana sputum kanaka i loko o ka vitro, a me ka homozygous mutation i loko o ka 507-533 amino acid codon māhele o ka rpoB gene i kumu kū'ē i ka Mycobacterium tuberculosis rifampicin.
-
Mycoplasma Hominis Nucleic Acid
He mea kūpono kēia kit no ka ʻike qualitative o Mycoplasma hominis (MH) i loko o ka ʻāpana mimi kāne a me nā ʻāpana huna huna wahine.
-
Herpes Simplex Virus Type 1/2，(HSV1/2) Nucleic Acid
Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o Herpes Simplex Virus Type 1 (HSV1) a me Herpes Simplex Virus Type 2 (HSV2) e kōkua i ka hoʻomaʻamaʻa a mālama ʻana i nā poʻe maʻi i manaʻo ʻia he maʻi HSV.
-
EB Virus Nucleic Acid
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o EBV i ke koko holoʻokoʻa o ke kanaka, plasma a me nā laʻana serum in vitro.
